197 related articles for article (PubMed ID: 1384325)
1. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.
Spritz RA; Holmes SA; Ramesar R; Greenberg J; Curtis D; Beighton P
Am J Hum Genet; 1992 Nov; 51(5):1058-65. PubMed ID: 1384325
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
Giebel LB; Spritz RA
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8696-9. PubMed ID: 1717985
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
Spritz RA; Giebel LB; Holmes SA
Am J Hum Genet; 1992 Feb; 50(2):261-9. PubMed ID: 1370874
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
Spritz RA; Holmes SA; Itin P; Küster W
J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of human piebaldism.
Spritz RA
J Invest Dermatol; 1994 Nov; 103(5 Suppl):137S-140S. PubMed ID: 7525736
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism.
Ezoe K; Holmes SA; Ho L; Bennett CP; Bolognia JL; Brueton L; Burn J; Falabella R; Gatto EM; Ishii N
Am J Hum Genet; 1995 Jan; 56(1):58-66. PubMed ID: 7529964
[TBL] [Abstract][Full Text] [Related]
7. Human piebaldism: relationship between phenotype and site of kit gene mutation.
Ward KA; Moss C; Sanders DS
Br J Dermatol; 1995 Jun; 132(6):929-35. PubMed ID: 7544995
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the c-kit protooncogene in the human developmental defect piebald trait.
Fleischman RA; Saltman DL; Stastny V; Zneimer S
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10885-9. PubMed ID: 1720553
[TBL] [Abstract][Full Text] [Related]
9. A recurrent deletion in the KIT (mast/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism.
Spritz RA; Holmes SA; Berg SZ; Nordlund JJ; Fukai K
Hum Mol Genet; 1993 Sep; 2(9):1499-500. PubMed ID: 7694728
[No Abstract] [Full Text] [Related]
10. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
Fleischman RA
J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
[TBL] [Abstract][Full Text] [Related]
11. Effect of the c-kit codon 584 Phe----Leu substitution demonstrated in human piebaldism.
Fleischman RA
Am J Hum Genet; 1992 Sep; 51(3):677-8. PubMed ID: 1379775
[No Abstract] [Full Text] [Related]
12. New KIT mutations in patients with piebaldism.
Murakami T; Fukai K; Oiso N; Hosomi N; Kato A; Garganta C; Barnicoat A; Poppelaars F; Aquaron R; Paller AS; Ishii M
J Dermatol Sci; 2004 Jun; 35(1):29-33. PubMed ID: 15194144
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the KIT and PDGFRA genes in a patient with piebaldism.
Spritz RA; Droetto S; Fukushima Y
Am J Med Genet; 1992 Nov; 44(4):492-5. PubMed ID: 1279971
[TBL] [Abstract][Full Text] [Related]
14. A novel KIT missense mutation in one Chinese family with piebaldism.
Yin XY; Ren YQ; Yang S; Xu SX; Zhou FS; Du WH; Lin D; Wang PG; Zhang SM; Zhang XJ
Arch Dermatol Res; 2009 Jun; 301(5):387-9. PubMed ID: 19430803
[TBL] [Abstract][Full Text] [Related]
15. Mice transgenic for Kit(V620A): recapitulation of piebaldism but not progressive depigmentation seen in humans with this mutation.
Tosaki H; Kunisada T; Motohashi T; Aoki H; Yoshida H; Kitajima Y
J Invest Dermatol; 2006 May; 126(5):1111-8. PubMed ID: 16456533
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism.
Fleischman RA; Gallardo T; Mi X
J Invest Dermatol; 1996 Nov; 107(5):703-6. PubMed ID: 8875953
[TBL] [Abstract][Full Text] [Related]
17. Polymerase chain reaction detection of a novel human KIT (mast/stem cell growth factor receptor) gene polymorphism by single-strand conformation polymorphism analysis or by SmaI or BstNI cleavage.
Spritz RA; Holmes SA
Hum Genet; 1993 Sep; 92(2):208-9. PubMed ID: 7690341
[TBL] [Abstract][Full Text] [Related]
18. Human piebaldism: six novel mutations of the proto-oncogene KIT.
Syrris P; Heathcote K; Carrozzo R; Devriendt K; Elçioglu N; Garrett C; McEntagart M; Carter ND
Hum Mutat; 2002 Sep; 20(3):234. PubMed ID: 12204004
[TBL] [Abstract][Full Text] [Related]
19. A novel KIT mutation results in piebaldism with progressive depigmentation.
Richards KA; Fukai K; Oiso N; Paller AS
J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations of KIT gene in two Korean patients: variegated shades of phenotypes in tyrosine kinase 1 domain.
Lee H; Oh SH; Koo KY; Suzuki T; Lee JS
J Dermatol Sci; 2014 Oct; 76(1):74-6. PubMed ID: 25176472
[No Abstract] [Full Text] [Related]
[Next] [New Search]